FDA Demands Zantac Recall



Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…

https://www.napolilaw.com/article/fda-demands-zantac-recall/

Comments

Popular posts from this blog

When Your Employer Does Not Keep Accurate Overtime Records

Doctors Continue To Struggle With Blood Clot Treatment

Coping with Recovery in COVID-19 Isolation